Clinical trial Recruiting at 1 site Observational Ages 20 and up

Evaluating new MRI techniques for lymphedema

Official title: Development and Optimization of Novel MRI Techniques on Evaluation of Therapeutic Effects for Lymphedema Secondary to Breast Cancer Treatment: An Integrated Study of Pre-clinical Animal Models and Clinical Follow-up

Run by National Taiwan University Hospital · NCT05804643 · Data updated 2026-11-12

This study is testing new MRI techniques to better understand and track lymphedema in breast cancer patients to improve their treatment outcomes.

Quick facts

Study typeObservational
Ages20 Years and up
SexAll
Enrollment210 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Taipei)
StatusRecruiting
StartedApril 10, 2023
Main results expectedDecember 2024
Study endsDecember 2026
Registry record updatedApril 19, 2023
Trial IDNCT05804643 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with breast cancer-related lymphedema.

Probably not a fit

Patients under 20 years old, pregnant individuals, or those with contraindications for MRI will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project investigates advanced imaging methods for assessing breast cancer-related lymphedema. It includes three sub-projects: one focuses on developing a pre-clinical rat model and novel MRI techniques, another optimizes clinical MRI methods for mapping lymphedema severity, and the third evaluates post-surgical therapeutic effects. The study aims to create a comprehensive imaging database for future reference and improve the understanding of lymphedema treatment outcomes through longitudinal monitoring.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic and monitoring tools for patients with lymphedema, enhancing treatment outcomes.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving imaging techniques for lymphedema assessment.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* adults with breast cancer related lymphedema

Exclusion Criteria:

* children younger than 20 years old
* pregnancy
* patients who have absolute contraindications regarding MRI scanning:

  1. The cardiac implantable electronic device (CIED) such as pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices.
  2. Metallic intraocular foreign bodies.
  3. Implantable neurostimulation systems
  4. Cochlear implants/ear implant: bone-anchored hearing aid (BAHA) cochlear implant type can be scanned on a 1.5-tesla scanner only after the patient removes the battery. Cochlear implant wrapping scheduling must take place before the patient's MRI appointment.
  5. Drug infusion pumps (insulin delivery, analgesic drugs, or chemotherapy pumps): If possible, the patient has to remove the device.
  6. Catheters with metallic components (Swan-Ganz catheter)
  7. Metallic fragments such as bullets, shotgun pellets, and metal shrapnel
  8. Cerebral artery aneurysm clips
  9. Magnetic dental implants
  10. Tissue expander
  11. Artificial limb
  12. Hearing aid

Where it's running

  • National Taiwan university hospital
    Taipei, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Li-Wei Kuo, Ph.D. — National Health Research Institutes, Taiwan
  • Study coordinator: Yeefan Lee, MD
  • Email: yeefanlee@ntu.edu.tw
  • Phone: +886-972653172

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.